Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer

SIMPLE SUMMARY: Using a first-principles approach, we demonstrate how standard-of-care therapies for bone metastatic prostate cancer (BMPCa) patients can be optimized with the use of routine measurements to significantly delay the evolution of resistant disease, potentially extending overall patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: Araujo, Arturo, Cook, Leah M., Frieling, Jeremy S., Tan, Winston, Copland, John A., Kohli, Manish, Gupta, Shilpa, Dhillon, Jasreman, Pow-Sang, Julio, Lynch, Conor C., Basanta, David
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7915310/
https://ncbi.nlm.nih.gov/pubmed/33567529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040677
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares